July 9, 2024 Edition

A monoclonal antibody prevented malaria in people for up to 36 weeks in a Phase 1 clinical trial.

Highly processed foods accounted for two-thirds of the calories consumed by youth in the U.S. in 2018, researchers found.

A study estimated that COVID-19 vaccinations prevented nearly 140,000 deaths in the U.S. by May 2021.

Researchers identified a protein that acts like a detergent to kill bacteria that get inside human cells.

Findings in lab-grown neurons derived from people with ALS suggested a strategy to treat both inherited and sporadic ALS.

A nasal spray of a COVID-19 vaccine protected hamsters and monkeys against serious disease and reduced the amount of virus in the nose.

High-dose buprenorphine treatment of opioid withdrawal in an emergency department appeared safe and provided symptom relief within a few hours.

A small study found that gene therapy delivered into the brain was safe and beneficial in treating a debilitating neurological disease.

Researchers developed a device to decode brain activity into words, allowing a person with paralysis to communicate in complete sentences.

A study found that a diet high in added fats, fried foods, processed meats, and sugary drinks was associated with a greater risk of sudden cardiac death, while a Mediterranean diet was associated with a lower risk.

By combining parts of spike proteins from different coronaviruses, researchers developed an mRNA vaccine that protected mice against a range of coronaviruses.

In studies in mice, a drug boosted the natural ability of the immune system to fight off antibiotic-resistant bacteria.

Medications to treat alcohol use disorder, although effective, are only being used to treat 1.6% of people with the disorder, according to a new study.

Researchers developed a malaria vaccination strategy that provided broad, long-lasting protection in controlled clinical trials.

Researchers developed a temporary pacemaker that is powered wirelessly and breaks down harmlessly in the body after use.

A study found that control over blood sugar and blood pressure has declined among people with diabetes after years of progress.

The immune response to the single-shot Janssen/Johnson & Johnson COVID-19 vaccine remained robust against variants of SARS-CoV-2.

A biomarker in blood could identify the presence of neurodegeneration in people with cognitive impairment.

Researchers discovered that the awake resting brain repeatedly replays compressed memories of a new skill being learned.

Researchers found that a drug called TEMPOL can shut down a key enzyme that the SARS-CoV-2 virus needs to copy itself.

Researchers treated sickle cell disease in mice by directly editing the defective hemoglobin gene that causes the disease.

Researchers identified clusters of brain cells that compete to promote either the persistence or disappearance of fearful memories.

Research revealed how certain mutations in circulating SARS-CoV-2 variants allow the virus to avoid neutralization by many antibodies.

Older, frail adults with heart failure who participated in a personalized physical rehab program improved their endurance, strength, balance, and quality of life.

A study found that placing tympanostomy tubes in young children did not reduce the overall number of ear infections any more than oral antibiotic treatment.

Researchers used an airway-on-a-chip that mimics living lung tissue to screen approved drugs for use against SARS-CoV-2.

Gene therapy restored immune system function to children with an inherited immune disorder with fewer side effects than existing therapies.